Related Experiment Video
Updated: Mar 3, 2026
05:48
Sampling, Identification and Characterization of Microplastics Release from Polypropylene Baby Feeding Bottle during Daily Use
Published on: July 24, 2021
6.3K
The case for chewable tablets: reducing single-use plastic waste in pediatrics
Lydia Lu1, Preeti Jaggi2, Andrew Smelser3
1Pediatric Infectious Disease, Children's Healthcare of Atlanta Inc, Atlanta, USA.
Summary
Pediatric liquid medications contribute significantly to plastic waste. Utilizing existing chewable formulations and adjusted dosing could substantially reduce this environmental burden.
Area of Science:
- Environmental Science
- Pediatric Pharmacology
- Healthcare Waste Management
Background:
- Pediatric medications, often liquid suspensions, are a major source of healthcare plastic waste.
- Weight-based dosing necessitates liquid formulations, increasing waste.
- Current alternative formulations and dosing strategies are underutilized.
Purpose of the Study:
- To assess the impact of pediatric medication formulations on plastic waste.
- To highlight the underutilization of alternative dosage forms and dosing strategies.
- To demonstrate how minor changes in medication administration can reduce plastic waste.
Main Methods:
- Literature review on pediatric medication formulations and waste generation.
- Analysis of current dosing practices and availability of alternative dosage forms.
- Modeling the potential reduction in plastic waste through optimized formulation use.
Main Results:
- Liquid pediatric medications are a significant contributor to plastic waste.
- Chewable tablet formulations and stair-step dosing recommendations exist but are not widely used.
- Optimizing formulation choice and dosing strategies shows potential for substantial plastic waste reduction.
Conclusions:
- Underutilization of alternative pediatric medication formulations contributes to plastic waste.
- Implementing existing chewable formulations and dosing strategies can decrease plastic waste.
- Small changes in pediatric medication administration practices can yield significant environmental benefits.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
411
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
340
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
01:23Oral Drug Delivery Systems: Introduction
85
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
85
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
387
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
387
01:26Oral Drug Delivery Systems: Continuous-Release Systems
82
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
82
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
293
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293